Purpose: Gastric mucosal neoplastic lesions should have characteristic endoscopic features for successful endoscopic submucosal dissection. Materials and Methods: Out of the 1,010 endoscopic submucosal dissection, we enrolled 62 patients that had the procedure cancelled. Retrospectively, whether the reasons for cancelling the endoscopic submucosal dissection were consistent with the indications for an endoscopic submucosal dissection were assessed by analyzing the clinical outcomes of the patients that had the surgery. Results: The cases were divided into two groups; the under-diagnosed group (30 cases; unable to perform an endoscopic submucosal dissection) and the over-diagnosed group (32 cases; unnecessary to perform an endoscopic submucosal dissection), according to the second endoscopic findings, compared with the index conventional white light image. There were six cases in the under-diagnosed group with advanced gastric cancer on the second conventional white light image endoscopy, 17 cases with submucosal invasion on endoscopic ultrasonography findings, 5 cases with a size greater than 3 cm and ulcer, 1 case with diffuse infiltrative endoscopic features, and 1 case with lymph node involvement on computed tomography. A total of 25 patients underwent a gastrectomy to remove a gastric adenocarcinoma. The overall accuracy of the decision to cancel the endoscopic submucosal dissection was 40% (10/25) in the subgroup that had the surgery. Conclusions: The accuracy of the decision to cancel the endoscopic submucosal dissection, after conventional white light image and endoscopic ultrasonography, was low in this study. Other diagnostic options are needed to arrive at an accurate decision on whether to perform a gastric endoscopic submucosal dissection.
Introduction
Gastric cancer is one of the leading causes of cancer related deaths in the world, and it is especially common in East Asian countries.(1) One of the major factors associated with improved survival of patients with gastric cancer is early detection. As a result of expansion of both nationwide cancer-screening programs and of private health check-ups, premalignant gastric lesions and early gastric cancer (EGC) are now detected with increasing frequency in Korea. ( 2) The endoscopic mucosal resection (EMR) has become one of the established treatment procedures for small early gastric cancers without any lymph node involvement and precancerous gastric lesions.(3) EMR is an effective technique for the removal of early GI tract neoplasm. Complication rates associated with the EMR are low. However, lesions over 20 mm cannot be resected in a single piece and piecemeal resection leads to local recurrence rates of up to 15%. (4, 5) A novel technique, the endoscopic submucosal dissection (ESD) has been proposed to guarantee en bloc resection. (6) (7) (8) we could enroll the patients with appropriate indication for gastric ESD, the benefit would be avoiding unnecessary surgery and also be avoding unnecessary ESD vice versa.
In this study, the clinical outcomes of cancelled ESD procedures were evaluated. The objective of this study was to determine the accuracy of the decision to cancel an ESD.
Materials and Methods

Patients
Out of 1,010 cases of gastric ESD performed from January 2007 to April 2010, 62 were included in this study. These patients had an ESD planned, but then cancelled. The mean follow-up period was 474.81±285.54 days. The patients with advanced gastric lesions on the initial conventional white light image (cWLI) were excluded.
The patients were divided into two groups: Under-diagnosed and over-diagnosed. For example, in cases where the initial diagnosis from a local clinic suggested the need for an ESD, the lesion might have been observed as more advanced than appropriate for an ESD on the second cWLI and endoscopic ultrasonography (EUS), and these cases were defined as under-diagnosed (unable or difficult to perform an ESD). By contrast, if the lesion on the ESD was vague in appearance such as with indistinct margins or as too small or more consistent with gastritis on biopsy, during the second cWLI, these cases were defined as over-diagnosed (unnecessary to perform an ESD). The institutional review board of our center approved this study.
Methods
When an ESD was planned, the expanded ESD indications were adopted in cases with adenocarcinoma. The expanded indications for EMR were suggested by Gotoda in 2000. Based on the report, at the National Cancer Center and other groups, the indications for ESD are: (i) non-ulcerated, differentiated-type mucosal carcinomas, regardless of tumor size; and (ii) differentiated-type mucosal carcinoma with an ulcer scar ≤30 mm. (11) If the target lesion did not meet the criteria for the procedure during the second cWLI such as in cases with advanced disease (i.e. submucosal or muscularis propria invasion on EUS, size over 3 cm with ulceration), the procedure was cancelled. In the case of dysplasia, the ESD was cancelled when the lesion to undergo ESD was vague in appearance with indistinct margins, too small, or was confirmed as gastritis on the biopsy from the second endoscopy.
All 62 patients were referred for ESD from local clinics. The endoscopic features and pathology from the local clinics were reviewed. The mean time lag between the first and second endoscopy was 37.65±15.12 days. The second endoscopy for the ESD (GIF-H260, GIF-H180, Olympus, Tokyo, Japan) was performed at our clinic by a single expert (SW Jeon), who has performed more than 1,000 gastric ESDs.
A radial scanning, 20-MHz catheter, probe (UM3R, Olympus), was used by the same physicians in all patients except the patients with advanced gastric cancer (AGC) features on second endoscopy.
The probe was passed through the instrument channel of a two channel endoscope (GIF-2T200, Olympus). When the ESD was cancelled, a repeat biopsy (defined as the second diagnosis) and another description of the target lesions was performed.
The reasons for cancelling the ESD were categorized into four groups in the under-diagnosed group: gross AGC features, submucosal invasion in the EUS, size ＞3 cm with ulceration, and diffuse infiltrative lesion. The consistency between the second diagnosis and the final surgical pathology in the patients that went to surgery was evaluated. In addition, the clinical and endoscopic data were analyzed to assess the relationship between the accuracy and variables that were assumed to be predictive of the accuracy associated with canceling the ESD. In the cases that underwent surgery, the clinical outcomes were reviewed and the accuracy of cancelled cases assessed.
Statistical analysis
A statistical software package (SPSS ver. 14.0, SPSS Inc., Chicago, IL, USA) was used for the data analysis. For assessment of the association between the accuracy of the decision and the study variables (i.e. category of size, location, endoscopic features, and pathology), the c 2 test was used, and the independent t-test for quantitative variables. P-values less than 0.05 were considered to be significant.
Results
Clinical characteristics of patients
The target lesions were more frequently located in the lower portion of the stomach. Macroscopic types were classified as el- Two centimeter elevated mucosal lesion was revealed as HGD on the initial diagnosis of a 63-year-old male (A). However, ulceration and a size over 3 cm were observed on the second cWLI 59 days later (B), therefore surgical treatment was performed. EGC was diagnosed on a 3 cm IIa lesion of the antrum in a 75-year-old female (C). However, the lesion already involved over 1/3 of the upper submucosa on the EUS performed 9 days later compared to the initial endoscopy (D). HGD = high grade dysplasia; cWLI = conventional white light image; EGC = early gastric cancer; EUS = endoscopic ultrasonography.
two atypical cells (3.3%). Twenty-five (40.3%) patients underwent surgical treatment and four (6.5%) patients underwent ESD later (Table 1) .
Clinical outcomes of the patients
Among the 62 cancelled cases, 30 (19 adenocarcinoma, 5 HGD, 5 LGD, 1 atypical cell in initial diagnosis) were under-diagnosed when referred, and consisted of six cases of gross AGC on the second cWLI (Fig. 1A, B ), 18 cases with submucosal invasion on the EUS (Fig. 1C, D) , four cases with a size over 3 cm and ulceration, one case with diffuse infiltrative endoscopic features and one case with lymph node involvement on computed tomography (CT) (Fig. 2) .
Thirty-two patients were over-diagnosed (1 atypical cells, 1 HGD, and 30 LGD on the initial diagnosis) and their pathology at the time of the second endoscopy was one adenocarcinoma, 17 dysplasias, 11 cases of chronic gastritis and three cases with no suspected mucosal lesions for re-biopsy. Adenocarcinoma identified on the re-biopsied cases underwent ESD later and three cases with dysplasia had ESD later.
Clinical outcomes in the under-diagnosed group (unable to perform an ESD)
In the under-diagnosed group, 25 patients underwent a gastrectomy (subtotal or total, according to the location) with D1-2 dissection. The clinical outcomes of these 25 operated patients are described in Table 2 . There was no lymph node involvement on the final surgical pathology. LGD, 1 atypical cell in initial diagnosis) were under-diagnosed when referred, and included six cases of gross AGC by endoscopic features, 17 cases with submucosal invasion on EUS findings, five cases over 3 cm with ulceration, one case with diffuse infiltrative endoscopic features and one case of lymph node involvement on CT. Twenty-five among the 30 under-diagnosed cases underwent subtotal gastrectomy and none had lymph node involvement. Thirty-two patients were over-diagnosed (1 atypical cell, 1 HGD, 30 LGD in initial diagnosis) and their pathology at the time of the second endoscopy was: 1 adenocarcinoma, 16 adenomas, 11 with chronic gastritis, and four cases with no suspected mucosal lesion for re-biopsy at the second endoscopy. Adenocarcinoma found in re-biopsied cases had ESD later and there were three cases that underwent ESD later with adenomas. ESD = endoscopic submucosal dissection; Adenoca = adenocarcinoma; HGD = high grade dysplasia; LGD = low grade dysplasia; AGC = advanced gastric cancer; EUS = endoscopic ultrasonography; LN = lymph node; CT = computed tomography; F/u = follow-up. 
Clinical Outcomes in the over-diagnosed group (unnecessary to perform an ESD)
In the over-diagnosed group, four cases underwent an ESD later. All 4 cases were considered unnecessary to perform ESD due to indistinctive margins on the second endoscopy. The time lag between the second diagnosis and the ESD performed later varied from 20 days to 227 days (Table 3) .
Clear margins were obtained by ESD in all four cases and the location of the final lesion on ESD was consistent with the initial location described at the local clinic.
Accuracy of the decision to cancel an ESD
The overall accuracy of the decision to cancel an ESD was 40% (10/25); 33.3% (2/6) in the gross AGC subgroup, 40% (2/5) in the over 3 cm with ulceration subgroup, 46.2% (6/13) in the submucosal invasion by EUS subgroup and none in the one suspected lymph node involvement case on CT (Table 4) . Lesion size, endoscopic features, pathology and location of the lesion were not associated with the decision accuracy in the statistical analysis.
Discussion
The LGD ESD = endoscopic submucosal dissection; F = female; M = male; HGD = high grade dysplasia; LGD = low grade dysplasia; Adenoca = adenocarcinoma. Values are presented as % (n). ESD = endoscopic submucosal dissection; AGC = advanced gastric cancer; Sm = submucosa; EUS = endoscopic ultrasonography; LN = lymph node; CT = computed tomography.
to perform an ESD, it is impossible to assess the precise invasion depth of the forceps biopsy. Thus, EUS is the first-choice imaging modality for determining the depth of invasion. (12, 14) A meta-analysis of 22 studies showed that the accuracy of EUS for T staging in gastric cancer ranges from 65% to 92%. ( To distinguish cancer invasion from ulcer fibrosis, a method of pattern analysis was introduced. This pattern analysis was based on the fact that ulcer fibrosis always has a fan-shaped spread, while cancer invades in an arched-shaped spread. However, micro-invasion into the ulcer fibrosis does not change the contours of the fanshaped ulcer fibrosis, so micro-invasion is not detectable by EUS.
By using this pattern analysis, it was reported that the diagnostic accuracy for depressed-type EGC with ulceration was 76.1%. (19) Contrast-enhanced EUS was recommended to be another method to improve the accuracy of EUS for lesions with ulcerous changes. 
